Variant report
Variant | nsv961421 |
---|---|
Chromosome Location | chr2:77552899-77554467 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556103346 | chr2:77552925-77552926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569957844 | chr2:77552927-77552928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73941206 | chr2:77552941-77552942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558776630 | chr2:77552956-77552957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6753318 | chr2:77552987-77552988 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs140192967 | chr2:77552988-77552989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533938161 | chr2:77553039-77553040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1505224 | chr2:77553054-77553055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555228319 | chr2:77553135-77553136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188874197 | chr2:77553163-77553164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544145476 | chr2:77553180-77553181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562466897 | chr2:77553181-77553182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10193607 | chr2:77553197-77553198 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs545036135 | chr2:77553225-77553226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76131488 | chr2:77553231-77553232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs193123129 | chr2:77553243-77553244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527421203 | chr2:77553244-77553245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547169349 | chr2:77553326-77553327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567138973 | chr2:77553333-77553334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12619282 | chr2:77553370-77553371 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs182682094 | chr2:77553390-77553391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116580728 | chr2:77553398-77553399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370028145 | chr2:77553403-77553404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538644608 | chr2:77553506-77553507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187721902 | chr2:77553525-77553526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566018100 | chr2:77553530-77553531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555707652 | chr2:77553548-77553549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555169201 | chr2:77553600-77553601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575096869 | chr2:77553605-77553606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544085357 | chr2:77553634-77553635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191602242 | chr2:77553667-77553668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577506858 | chr2:77553716-77553717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs367920309 | chr2:77553738-77553739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146931497 | chr2:77553765-77553766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs137863697 | chr2:77553768-77553769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527357814 | chr2:77553769-77553770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567420523 | chr2:77553780-77553781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538759161 | chr2:77553828-77553829 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375679759 | chr2:77553858-77553859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs290039 | chr2:77553930-77553931 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs72809167 | chr2:77553931-77553932 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576010128 | chr2:77553987-77553988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538499200 | chr2:77553996-77553997 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529836737 | chr2:77554017-77554018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558223612 | chr2:77554028-77554029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549988385 | chr2:77554065-77554066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115751483 | chr2:77554075-77554076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12468248 | chr2:77554102-77554103 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs372446871 | chr2:77554105-77554106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552259024 | chr2:77554206-77554207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77549200-77554000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr2:77553800-77556000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr2:77553800-77556200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr2:77554000-77554200 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr2:77554000-77556000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr2:77554000-77556200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr2:77554000-77556400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:77554000-77556400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:77554400-77555400 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr2:77554400-77556400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |